vs
Diversified Energy Co（DEC）与PHIBRO ANIMAL HEALTH CORP（PAHC）财务数据对比。点击上方公司名可切换其他公司
Diversified Energy Co的季度营收约是PHIBRO ANIMAL HEALTH CORP的1.8倍（$666.5M vs $373.9M），Diversified Energy Co净利率更高（29.3% vs 7.3%，领先22.0%），Diversified Energy Co自由现金流更多（$280.0M vs $8.3M）
DTE能源是一家总部位于底特律的综合能源企业，在美国与加拿大开展能源相关业务的开发与运营。公司业务板块涵盖电力与燃气公用事业，其中电力业务为密歇根州220万客户服务，燃气业务则服务于该州130万客户。
菲宝罗动物保健公司是一家美国动物健康与矿物质营养企业，主营产品涵盖抗菌药、抗球虫药、驱虫药，以及畜禽营养补充剂、疫苗等。公司下设矿物质营养、功能材料、动物健康三大业务板块，收入主要来源于上述板块，业务遍及美国、拉美、加拿大、欧洲、中东、非洲及亚太地区。
DEC vs PAHC — 直观对比
营收规模更大
DEC
是对方的1.8倍
$373.9M
净利率更高
DEC
高出22.0%
7.3%
自由现金流更多
DEC
多$271.8M
$8.3M
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $666.5M | $373.9M |
| 净利润 | $195.5M | $27.5M |
| 毛利率 | — | 35.5% |
| 营业利润率 | 37.6% | 13.5% |
| 净利率 | 29.3% | 7.3% |
| 营收同比 | — | 20.9% |
| 净利润同比 | — | 762.1% |
| 每股收益（稀释后） | — | $0.67 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DECPAHC
| Q4 25 | $666.5M | $373.9M | ||
| Q3 25 | $499.8M | $363.9M | ||
| Q2 25 | $600.3M | $378.7M | ||
| Q1 25 | — | $347.8M | ||
| Q4 24 | — | $309.3M | ||
| Q3 24 | — | $260.4M | ||
| Q2 24 | — | $273.2M | ||
| Q1 24 | — | $263.2M |
净利润DECPAHC
| Q4 25 | $195.5M | $27.5M | ||
| Q3 25 | $171.1M | $26.5M | ||
| Q2 25 | $297.7M | $17.2M | ||
| Q1 25 | — | $20.9M | ||
| Q4 24 | — | $3.2M | ||
| Q3 24 | — | $7.0M | ||
| Q2 24 | — | $752.0K | ||
| Q1 24 | — | $8.4M |
毛利率DECPAHC
| Q4 25 | — | 35.5% | ||
| Q3 25 | — | 32.9% | ||
| Q2 25 | 44.7% | 29.0% | ||
| Q1 25 | — | 30.1% | ||
| Q4 24 | — | 32.9% | ||
| Q3 24 | — | 32.1% | ||
| Q2 24 | — | 31.9% | ||
| Q1 24 | — | 30.2% |
营业利润率DECPAHC
| Q4 25 | 37.6% | 13.5% | ||
| Q3 25 | 36.2% | 14.1% | ||
| Q2 25 | 48.5% | 8.9% | ||
| Q1 25 | — | 9.6% | ||
| Q4 24 | — | 8.3% | ||
| Q3 24 | — | 6.8% | ||
| Q2 24 | — | 6.7% | ||
| Q1 24 | — | 7.6% |
净利率DECPAHC
| Q4 25 | 29.3% | 7.3% | ||
| Q3 25 | 34.2% | 7.3% | ||
| Q2 25 | 49.6% | 4.5% | ||
| Q1 25 | — | 6.0% | ||
| Q4 24 | — | 1.0% | ||
| Q3 24 | — | 2.7% | ||
| Q2 24 | — | 0.3% | ||
| Q1 24 | — | 3.2% |
每股收益（稀释后）DECPAHC
| Q4 25 | — | $0.67 | ||
| Q3 25 | $2.14 | $0.65 | ||
| Q2 25 | $3.67 | $0.43 | ||
| Q1 25 | — | $0.51 | ||
| Q4 24 | — | $0.08 | ||
| Q3 24 | — | $0.17 | ||
| Q2 24 | — | $0.02 | ||
| Q1 24 | — | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $29.7M | $74.5M |
| 总债务越低越好 | $2.7B | $624.2M |
| 股东权益账面价值 | $984.1M | $332.4M |
| 总资产 | $6.2B | $1.4B |
| 负债/权益比越低杠杆越低 | 2.76× | 1.88× |
8季度趋势，按日历期对齐
现金及短期投资DECPAHC
| Q4 25 | $29.7M | $74.5M | ||
| Q3 25 | — | $85.3M | ||
| Q2 25 | $23.7M | $77.0M | ||
| Q1 25 | — | $70.4M | ||
| Q4 24 | — | $67.1M | ||
| Q3 24 | — | $89.8M | ||
| Q2 24 | — | $114.6M | ||
| Q1 24 | — | $98.7M |
总债务DECPAHC
| Q4 25 | $2.7B | $624.2M | ||
| Q3 25 | — | $628.0M | ||
| Q2 25 | — | $631.7M | ||
| Q1 25 | — | $635.4M | ||
| Q4 24 | — | $639.1M | ||
| Q3 24 | — | $295.2M | ||
| Q2 24 | — | $312.1M | ||
| Q1 24 | — | — |
股东权益DECPAHC
| Q4 25 | $984.1M | $332.4M | ||
| Q3 25 | — | $311.7M | ||
| Q2 25 | $727.7M | $285.7M | ||
| Q1 25 | — | $266.0M | ||
| Q4 24 | — | $246.8M | ||
| Q3 24 | — | $258.5M | ||
| Q2 24 | — | $256.6M | ||
| Q1 24 | — | $270.1M |
总资产DECPAHC
| Q4 25 | $6.2B | $1.4B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | $5.7B | $1.4B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $966.3M | ||
| Q2 24 | — | $982.2M | ||
| Q1 24 | — | $979.0M |
负债/权益比DECPAHC
| Q4 25 | 2.76× | 1.88× | ||
| Q3 25 | — | 2.01× | ||
| Q2 25 | — | 2.21× | ||
| Q1 25 | — | 2.39× | ||
| Q4 24 | — | 2.59× | ||
| Q3 24 | — | 1.14× | ||
| Q2 24 | — | 1.22× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $464.6M | $19.4M |
| 自由现金流经营现金流 - 资本支出 | $280.0M | $8.3M |
| 自由现金流率自由现金流/营收 | 42.0% | 2.2% |
| 资本支出强度资本支出/营收 | 27.7% | 3.0% |
| 现金转化率经营现金流/净利润 | 2.38× | 0.70× |
| 过去12个月自由现金流最近4个季度 | — | $47.3M |
8季度趋势，按日历期对齐
经营现金流DECPAHC
| Q4 25 | $464.6M | $19.4M | ||
| Q3 25 | — | $9.3M | ||
| Q2 25 | $264.1M | $21.3M | ||
| Q1 25 | — | $43.2M | ||
| Q4 24 | — | $3.1M | ||
| Q3 24 | — | $12.6M | ||
| Q2 24 | — | $28.4M | ||
| Q1 24 | — | $11.4M |
自由现金流DECPAHC
| Q4 25 | $280.0M | $8.3M | ||
| Q3 25 | — | $-4.5M | ||
| Q2 25 | — | $8.1M | ||
| Q1 25 | — | $35.4M | ||
| Q4 24 | — | $-4.7M | ||
| Q3 24 | — | $3.0M | ||
| Q2 24 | — | $15.4M | ||
| Q1 24 | — | $1.7M |
自由现金流率DECPAHC
| Q4 25 | 42.0% | 2.2% | ||
| Q3 25 | — | -1.2% | ||
| Q2 25 | — | 2.1% | ||
| Q1 25 | — | 10.2% | ||
| Q4 24 | — | -1.5% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 5.6% | ||
| Q1 24 | — | 0.6% |
资本支出强度DECPAHC
| Q4 25 | 27.7% | 3.0% | ||
| Q3 25 | — | 3.8% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | — | 2.5% | ||
| Q3 24 | — | 3.7% | ||
| Q2 24 | — | 4.8% | ||
| Q1 24 | — | 3.7% |
现金转化率DECPAHC
| Q4 25 | 2.38× | 0.70× | ||
| Q3 25 | — | 0.35× | ||
| Q2 25 | 0.89× | 1.24× | ||
| Q1 25 | — | 2.07× | ||
| Q4 24 | — | 0.97× | ||
| Q3 24 | — | 1.81× | ||
| Q2 24 | — | 37.80× | ||
| Q1 24 | — | 1.36× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DEC
暂无分部数据
PAHC
| Medicated Feed Additives And Others | $202.1M | 54% |
| Mineral Nutrition | $68.9M | 18% |
| Nutritional Specialties | $50.2M | 13% |
| Vaccines | $37.6M | 10% |
| Performance Products | $15.0M | 4% |
